Alphabet-Owned Firm to Begin Human Trials for AI-Developed Cancer Drug
Isomorphic Labs, a pharmaceutical company owned by Alphabet, is preparing to begin human trials for its cancer drug, developed using AlphaFold 3, an advanced AI tool created in collaboration with Google DeepMind. Founded in 2021, Isomorphic Labs has used AlphaFold 3 to predict complex protein structures and design new oncology drugs. The company is now…